Published in Vaccine Weekly, October 30th, 2002
In the study, researchers used a nasal spray to deliver a protein that, under normal circumstances, contributes to inflammation of the cells that line the inner walls of blood vessels. Exposing rats to this substance, called E-selectin, programs blood cells called...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2002-10-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.